BLISS GVS PHARMA
|
|
BOM : 506197     NSE : BLISSGVS     | |
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Good [Stock is Cheap] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Aug 12,2022 |
Price(EOD): ₹ 76.65
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 795.63 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
BLISS GVS PHARMA | -2.9% | 0.7% | -32% |
SUN PHARMACEUTICAL INDUSTRIES | -0.2% | 6.2% | 16% |
DIVIS LABORATORIES | -4.7% | -1.3% | -19.7% |
DR REDDYS LABORATORIES | 2.6% | -5.4% | -11% |
CIPLA | -0.7% | 7.8% | 13.8% |
GLAND PHARMA | 4.5% | -3.4% | -44.2% |
PIRAMAL ENTERPRISES | 11.2% | 13.1% | -31.4% |
CADILA HEALTHCARE | 8.3% | 5.1% | -33.9% |
TORRENT PHARMACEUTICALS | -1.1% | 3.5% | 1.4% |
FUNDAMENTAL ANALYSIS OF BLISS GVS PHARMA
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF BLISS GVS PHARMA
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
52.86
P/E Calculated based on EPS of 1.45
[ Mar2022 - Consolidated Results ] 0.98
P/B Calculated based on Book Value of 78.01
[ Mar2022 - Consolidated Results ] 1.04
P/S Calculated based on Revenues of 767.97 Cr
[ TTM - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
-19% -43% -43% |
SHARE PRICE MOMENTUM OF BLISS GVS PHARMA
BLISS GVS PHARMA vs SENSEX
DEBT OF BLISS GVS PHARMA
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2022 2021 2020 Avg_3yrs |
0.1 0.12 0.13 0.12 |
0.13 0.15 0.16 0.15 |
[Last Annual Data : Mar2022]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF BLISS GVS PHARMA
Pledged Promoter Shares |
0 % | |
---|---|---|
As on : Jun2022 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF BLISS GVS PHARMA
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
12.93% 92.67% 48.17% 17.1% |
12.2% 12.28% 6.84% 5.15% |
QtrlyTrend |
8 | |
Latest Qtr: Jun2022 | ||
Quarterly Result Analysis → |
BLISS GVS PHARMA related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE ALLCAP | 1.7% | 9.8% | 8.8% |
S&P BSE SMALL CAP | 1.3% | 8.2% | 4.9% |
S&P BSE MIDSMALLCAP | 1.3% | 8.7% | 6.2% |
S&P BSE HEALTHCARE | -0.9% | 4% | -12.6% |
You may also like the below Video Courses
FAQ about BLISS GVS PHARMA
Is BLISS GVS PHARMA good for long term investment?
As on Aug 12,2022, the Fundamentals of BLISS GVS PHARMA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of BLISS GVS PHARMA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is BLISS GVS PHARMA UnderValued or OverValued?
As on Aug 12,2022, BLISS GVS PHARMA is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of BLISS GVS PHARMA ?
As on Aug 12,2022, the Intrinsic Value of BLISS GVS PHARMA is Rs. 135.04 determined based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 95.18
Fair Value [Median EV / Sales Model] : Rs. 135.18
Fair Value [Median Price / Sales Model] : Rs. 135.04
Median Fair Value of BLISS GVS PHARMA : Rs. 135.04
Is BLISS GVS PHARMA trading at a Premium or Discount?
As on Aug 12,2022, BLISS GVS PHARMA is trading at a Discount of -43% based on the estimates of Median Intrinsic Value!SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
